Cancer Research and Treatment

Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis

Asia-Pacific Journal of Clinical Oncology.2022; 18(1): 7. CrossRef

Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial

Gabriel Glockzin, Florian Zeman, Roland S. Croner, Alfred Königsrainer, Jörg Pelz, Michael A. Ströhlein, Beate Rau, Dirk Arnold, Michael Koller, Hans J. Schlitt, Pompiliu Piso

Clinical Colorectal Cancer.2018; 17(4): 285. CrossRef

Treatment of peritoneal metastases from small bowel adenocarcinoma

Koen P. Rovers, Eelco de Bree, Yutaka Yonemura, Ignace H. de Hingh

International Journal of Hyperthermia.2017; 33(5): 571. CrossRef

Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis

T.A. Bin Traiki, O.M. Fisher, S.J. Valle, R.N. Parikh, M.A. Kozman, D. Glenn, M. Power, W. Liauw, N.A. Alzahrani, D.L. Morris

European Journal of Surgical Oncology (EJSO).2017; 43(10): 1939. CrossRef

Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis

C. Demtröder, W. Solass, J. Zieren, D. Strumberg, U. Giger‐Pabst, M.‐A. Reymond

Colorectal Disease.2016; 18(4): 364. CrossRef

Therapeutic options for peritoneal metastasis arising from colorectal cancer

Gabriel Glockzin, Hans J Schlitt, Pompiliu Piso

World Journal of Gastrointestinal Pharmacology and Therapeutics.2016; 7(3): 343. CrossRef

Challenges in the multidisciplinary management of stage IV colon and rectal cancer

Pompiliu Piso, Dirk Arnold, Gabriel Glockzin

Expert Review of Gastroenterology & Hepatology.2015; 9(3): 317. CrossRef

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis

Gabriel Glockzin, Michael Gerken, Sven A Lang, Monika Klinkhammer-Schalke, Pompiliu Piso, Hans J Schlitt

Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy?

H. Ishida, K. Kumamoto, K. Ishibashi, S. Hatano, T. Matsuzawa, N. Okada, Y. Kumagai, H. Baba, N. Haga

Techniques in Coloproctology.2013; 17(6): 647. CrossRef

Peritoneal carcinomatosis of colorectal origin: is it really an end-stage disease?

Techniques in Coloproctology.2013; 17(6): 619. CrossRef

Peritoneal carcinomatosis from colorectal cancer: hyperthermic intraperitoneal chemotherapy and the role of systemic chemotherapy

Colorectal Cancer.2013; 2(5): 449. CrossRef

Role of Chemotherapy in Peritoneal Carcinomatosis in Metastatic Colorectal Cancer

Jan Franko, Charles D. Goldman, Kiran K. Turaga

Current Colorectal Cancer Reports.2013; 9(3): 242. CrossRef

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

Gabriel Glockzin, Justine Rochon, Dirk Arnold, Sven A Lang, Frank Klebl, Florian Zeman, Michael Koller, Hans J Schlitt, Pompiliu Piso

A Long Survived Case of Transverse Colon Cancer with Peritoneal Dissemination Treated by Multidisciplinary Treatment Including Hyperthermic Intraperitoneal Chemotherapy

Toshiyuki Nakazawa, Takanori Goi, Mituhiro Morikawa, Kenji Koneri, Makoto Murakami, Yasuo Hirono, Atushi Iida, Kanji Katayama, Akio Yamaguchi, Atomu Murai

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons).2012; 37(6): 1136. CrossRef